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Abstract
Background: The offer of free nicotine replacement therapy (NRT) can be a cost-effective marketing strategy to
induce smokers to call a telephone quitline for quitting assistance. However, the most cost-effective supply of free
NRT to provide to smokers who call a quitline remains unknown. This study tests the hypothesis that smokers who
call a telephone quitline and are given more free nicotine patches would report higher quit rates upon follow-up
12 months later.
Methods: A quasi-experimental design was used to assess nicotine patch usage patterns and quit rates among
five groups of smokers who called the New York State Smokers’ Quitline (NYSSQL) between April 2003 and May
2006 and were mailed 2-, 4-, 6- or 8-week supplies of free nicotine patches. The study population included 2,442
adult (aged 18 years or older) current daily smokers of 10 or more cigarettes per day, who were willing to make a
quit attempt, and reported no contraindications for using the nicotine patch. Outcome variables assessed included
the percentage of smokers who reported that they had not smoked for at least 7-days at the time of a 12 months
telephone follow-up survey, sustained quitting, delayed quitting and nicotine patch use.
Results: Quit rates measured at 12 months were higher for smokers in the groups who received either 2, 6, or
8 weeks of free patches. The lowest quit rate was observed among the group of Medicaid/uninsured smokers who
were eligible to receive up to six weeks of free patches. The quit rate for the 4-week supply group did not differ
significantly from the 6-week or 8-week groups. These patterns remained similar in an intent-to-treat analysis of
12-month quit rates and in an analysis of sustained quitting.
Conclusion: No clear cut dose response relationship was observed between the number of free nicotine patches
sent to smokers and smoking outcomes. Baseline diferences in the characteristics of the groups compared could
account for the null findings, and a more definitive randomized trial is warranted.
Background
Research has demonstrated that the offer of free nico-
tine replacement therapy (NRT) can be a cost-effective
marketing strategy to induce large numbers of smokers
to call a telephone quitline for quitting assistance [1-3].
Our research has also shown that quit rates are
increased in those who received NRT in addition to tel-
ephone counseling support compared to those who
received counseling support alone [4]. However, the
most cost-effective supply of free NRT to provide to
smokers who call a quitline remains unknown.
The labeling for nicotine medications recommends
that smokers use the medication for at least eight to 12
weeks. This recommendation is based on the observa-
tion that most of those trying to stop smoking relapse
back to smoking within the first three months of quit-
ting [5,6]. Clinical trials evaluating the efficacy of NRT
have typically offered smokers a minimum of eight to 12
weeks of treatment [7]. While studies have tended to
find a positive correlation between the duration of NRT
use and cessation, it is not clear from these studies
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increases their odds of quitting. For example, a reason-
able alternative explanation for the observed positive
association between the use of NRT and quit rates is
that those who are no longer smoking remain compliant
with using the medication while those who relapse back
to smoking discontinue use of the medication [8-12].
Only two randomized trials have examined the effects of
varying the duration of NRT, and neither found any
benefit from extending treatment from 12 weeks to 18
or 26 weeks [10,11]. However, neither of these studies
addressed the value of giving smokers different amounts
of free medications at the outset of their quit attempt.
NRT helps people to stop smoking by lessening nico-
tine withdrawal symptoms after quitting which for many
smokers last about two weeks [13-17]. The relatively
short duration of nicotine withdrawal symptoms is con-
sistent with our previously reported observation of simi-
lar quit rates among smokers given a 1-, 2-, or 6-week
supplies of free nicotine patches [2].
The data presented in this paper extend our earlier
studies comparing patch usage patterns and quit rates
among smokers given different amounts of free patches
[2,4]. Subjects in this study included adult smokers who
contacted the New York State Smokers’ Quitline
(NYSSQL) and received a 2-, 4-, 6-, or 8-week supplies
of nicotine patches along with a stop smoking guide and
brief telephone counseling. The data from this study
allow us to test the hypothesis that smokers given more
nicotine patches would report higher quit rates upon
follow-up 12 months later.
Methods
A quasi-experimental design was used to compare five
groups of smokers (n = 2,442) who received free nico-
tine patches mailed to them by the NYSSQL between
April 2003 and May 2006. The groups were similar in
t h a ta l ls u b j e c t sh a dt om e e tt h es a m ec o r ec r i t e r i ai n
order to be eligible to get the free nicotine patches
made available through the NYSSQL. These core criteria
required participants to be 18 years of age or older, cur-
rent daily smokers of 10 or more cigarettes per day,
willing to make a quit attempt in the next fourteen days
(seven days for the 6 week program), receive a follow-up
phone call to determine their smoking status, and report
no contraindications for using the nicotine patch. In
addition to the free nicotine patches, participants were
mailed an instruction sheet on how to use the medica-
t i o n sa n dac o p yo ft h eN Y S S Q L ’s Break Loose stop
smoking guide. As part of routine service, the NYSSQL
attempted to call all smokers who received the free
nicotine patches within two to four weeks of shipment
of the NRT. The purpose of the callback was to make
sure callers received the nicotine patches and
understood the information packet, and to provide
counseling support to assist their quit attempt. Medicaid
and uninsured smokers (Group 3 described below)
received up to four additional proactive counseling calls.
The availability of the free NRT was promoted
through various media strategies, including press
releases, TV, radio, direct mail, word of mouth, and
print advertisments throughout New York State. Differ-
ent promotional strategies were used at different times
and overlapped among the groups.
Five Groups of Smokers
While all subjects were similar with regards to the core
eligibility criteria for getting the free patches, the five
groups of subjects did differ in terms of the time frame
when they were recruited into the study, the amount of
free nicotine patches mailed to them, and health insur-
ance status. Table 1 gives a brief description of each of
the five groups of smokers compared in this study, and
each of these groups is briefly described below.
The first group of subjects consists of 19,852 privately
insured smokers across New York State who called the
NYSSQL between November 2004 and August 2005,
when the NYSSQL began routinely providing free
2-week “starter kits” of either 21 mg or 14 mg nicotine
patches.
The second group of subjects consists of 38,667 pri-
vately insured smokers across New New York State who
called the NYSSQL between September 2005 through
May 2006, when a special promotion provided a starter
kit containing a 4-week supply of either 21 mg or
14 mg nicotine patches.
The third group of subjects consists of 19,589 Medi-
caid or uninsured smokers across New York State who
called the NYSSQL between November 2004 and May
2006. Medicaid and uninsured smokers were eligible to
receive up to 6-weeks of free nicotine patches (i.e.,
4 weeks of 21 mg patches plus 2 weeks of 14 mg
patches, or 4 weeks of 14 mg patches plus 2 weeks of 7
mg patches) contingent upon their agreement to receive
up to four proactive counseling calls from the NYSSQL
and reporting of progress towards quitting (i.e., used the
patches previously sent to them, motivated to continue
with quit plan) within two weeks of receiving their
2-week or 4-week starter kit of free patches.
The fourth group of smokers to receive free nicotine
patches from the NYSSQL resided in New York City
and was offered a 6-week supply between April 2 and
May 14, 2003. The free patch give away program was
sponsored by the New York City Department of Health
and Mental Hygiene in collaboration with the NYSSQL
and coincided with implementation of New York City’s
smoke-free workplace law. In a single mailing, 35,334
eligible smokers, regardless of health insurance status,
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and a 2-week supply of 14 mg patches.
The fifth group consisted of 2,000 smokers identified
between April and June 2004, who had no health insur-
ance and were mailed a single package containing a
total of 8 weeks of nicotine patches as follows: a 4 week
supply of 21 mg patches, a 2 week supply of 14 mg
patches, and a 2 week supply of 7 mg patches.
Follow-up of enrolled smokers
To evaluate patch usage patterns, smoking behavior, and
satisfaction with service outcomes, a standardized brief
telephone follow-up interview with a random sample of
callers was conducted a two points following subject
enrollment. Initially, subjects were contacted by tele-
phone between three and seven months (on average)
after contacting the quitline. Those who completed the
initial telephone follow-up interview were recontacted
again at 12 months after enrollment to reassess smoking
status. The telephone survey protocol was developed at
Roswell Park Cancer Institute and approved by its Insti-
tutional Review Board.
The main outcome variable examined in this paper is
the percentage of smokers who reported that they had
quit smoking at the time of the 12 month follow-up
interview. Subjects who reported that they had not
smoked in the 7 days prior to the follow-up interview
were defined as having quit smoking.
The 7-day point prevalence quit rate at 12 months fol-
low-up was computed in two ways. First, we estimated
the quit rate at the time of the 12 month follow-up inter-
view for each group based on the achieved sample, under
the assumption that those lost to follow-up were missing
at random. Second, we estimated the quit rate for each
group based on an intent-to-treat basis assuming that
those lost to follow-up had all returned to smoking.
Also, since we assessed smoking status at two different
times after enrollment in the program we were able to
compute three additional smoking outcome measures,
one reflecting sustained quitting, another reflecting
relapse back to smoking, and the third measuring
delayed quitting. Sustained quitting was defined as the
percentage of subjects in each group who reported not
smoking at both the initial follow-up interview and
again at the time of the 12 month follow-up interview.
Relapsed back to smoking was defined as the percentage
of subjects who at the time of the initial follow-up inter-
view were not smoking, but who reported that they were
smoking again when contacted at the time of the 12
month follow-up interview. Delayed quitting was defined
as the percentage of subjects who were smoking at the
time of the initial follow-up interview who were not
smoking at the time of the 12 month follow-up
interview.
Nicotine patch usage was assessed by asking subjects
at the time of their initial follow-up survey to report
how many of the patches sent to them in the mail they
had used and if they had purchased additional NRT
beyond those sent for free in the mail. For analysis pur-
poses we categorized subjects by the number of free
Table 1 Description of the five groups of smokers given free nicotine patches
Amount of free nicotine patches sent to smokers Group 1
2-week
supply
Group 2
4-week
supply
Group 3
6-week supply contingent
upon first 2-weeks of use
Group 4
6-week
supply
Group 5
8-week
supply
Number of Participants 19,852 38,667 19,859 35,334 2,000
Survey Sample Size 490 588 731 1,386 707
Program Dates 11/2004 -
8/2005
9/2005 -
5/2006
11/2004 - 5/2006 4/2003 -
5/2003
4/2004 -
6/2004
Mean duration of follow-up for the initial
follow-up survey (months)
3.14 3.12 3.15 5.51 7.24
Response rate initial follow-up survey* 69.0% 69.0% 45.2% 63.7% 68.7%
Number of eligible subjects who completed
the initial follow-up survey
338 406 332 880 486
Mean duration of follow-up for the 12-month
follow-up survey (months)
12.85 12.08 12.03 14.00 12.50
Response rate 12-month follow-up survey** 68.6% 56.9% 50.0% 65.6% 73.3%
Number of eligible subjects who completed both
surveys
232 231 166 577 356
Overall response rate 12-month follow-up survey*** 47.3% 39.3% 22.7% 41.6% 50.3%
*Initial follow-up response rate defined as the number of completed interviews among those considered eligible for follow-up (defined as those with working
phone numbers).
**12-month response rate defined as the number of completed interviews among those who completed the initial follow-up survey
***Overall response rate defined as the number of completed interviews among those initially eligible for follow-up.
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used.
Table 1 shows the number of participants, the survey
sample size, and response rates for each of the five
groups. The response rates varied significantly between
the groups ranging from 23% to 50%. Compared to
responders, non-responders in each group were also
signicantly more likely to be younger age (i.e., 18-35
years compared to >35 years) and non-white (data not
shown). Non-responders to the 12 month follow-up
interviewer were also somewhat more likely to report
smoking at the time of the initial follow-up interview
compared to responders.
Statistical Analysis
All data analyses were conducted using SPSS 14.0.
Descriptive statistics from the initial follow-up telephone
surveys were used to assess patterns of nicotine patch
use and to describe smoking outcomes for each group.
To compare differences between groups in their quit
rate measured at 12 months we used analysis of covar-
iance to compare the mean differences for each of the
five outcome variables between each group adjusted for
the following potential confounders: age, gender, race
(categorized as: White-Non-Hispanic, Black-Non-Hispa-
nic, Hispanic, and other), education (dichotomized as:
level high school graduate or less, more years of educa-
tion beyond high school), and number of cigarettes
smoke per day (CPD) at time of enrollment. Since this
was an exploratory study with multiple comparisons (10
for each outcome measure) made between groups, we
have adjusted p-values using the Bonferroni correction
to try to avoid making any spurious conclusions about
group differences [18].
Characteristics of the Five Groups
Table 2 shows that the five study groups were similar in
terms of gender and number of cigarettes smoked per
day. The groups also differed in expected ways with
respect to age, race/ethnicity, education, and health
insurance status. Specifically, participants in Group 3
(Medicaid/uninsured group) and Group 5 (uninsured
only group) were younger and less educated compared
to the other groups. Groups 3, 4 and 5 also included
more diverse smokers based on race and ethnicity com-
pared to Groups 1 and 2. By definition, Groups 1 and 2
included only privately insured callers while Group 5
included only uninsured callers. Group 3 consisted of
Table 2 Characteristics of the five groups of smokers given free nicotine patches
Amount of free nicotine
patches sent to smokers
Group 1
2-week supply
Group 2
4-week supply
Group 3
6-week supply contingent
upon first 2-weeks of use
Group 4
6-week supply
Group 5
8-week supply
CPD at Baseline
10-19 CPD 31.1% 29.0% 28.4% 23.5% 30.3%
20-30 CPD 40.8% 44.6% 40.5% 43.9% 50.4%
31 + CPD 28.1% 26.5% 31.1% 32.6% 19.2%
Gender
Male: 45.0% 42.1% 48.5% 43.4% 47.9%
Female: 55.0% 57.9% 51.5% 56.6% 52.1%
Age†
18-34: 22.5% 23.2% 37.7% 21.8% 31.3%
35-54: 52.1% 57.4% 53.3% 57.8% 52.9%
55+: 25.4% 19.5% 9.0% 20.4% 15.8%
Race/ethnicity†
White non-Hispanic 72.2% 81.0% 64.8% 52.1% 65.4%
Black non-Hispanic 14.2% 9.9% 17.2% 25.9% 18.6%
Hispanic 7.4% 6.7% 13.3% 14.9% 8.9%
Other 6.2% 2.5% 4.8% 7.2% 7.2%
Education†
High School or Less 46.7% 42.7% 54.9% 43.4% 53.2%
Greater than High School 53.3% 57.3% 45.1% 56.6% 46.8%
Health Insurance
Private 100.0% 100.0% 00.0 69.3% 0.0%
Medicaid 0.0% 0.0% 40.6 18.3% 0.0%
Uninsured 0.0% 0.0% 59.4 9.6% 100.0%
Other/unknown 0.0% 0.0% 00.0 2.8% 0.0%
† Age, Race/ethnicity, Education - Chi-square test: p-value < 0.01.
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Group 4 participants (NYC smokers who received
6-weeks of NRT) included 69% privately insured, 18%
Medicaid insured, 10% uninsured and 3% other or
unknown insurance status.
Results and Discussion
NRT Usage Patterns
Table 3 describes the nicotine patch usage patterns
across the five groups. The number of patches used did
differ significantly between groups with a chi-square test
resulting in a p-value of < 0.01. Most subjects reported
using at least some of the patches sent to them in the
mail, with generally similar usage patterns observed for
Groups 1 to 3 and for Groups 4 and 5. The number of
patches reportedly used was related to the amount of
free patches sent to subjects, with a significantly greater
number of patches used by those receiving the 6- and
8-week supplies relative to those who only received a
2- or 4-week supply of free patches, with the exception
of those who received the 6-week supply of free patches
contingent upon use of the initial supply of patches sent
to them. Members of Group 3 (6 weeks supply contin-
gent upon first two weeks of use) were about as likely as
those who received 4-weeks of free patches to report
using more than 14 patches and substantially less likely
to report using more than 14 patches compared to in
Groups 4 and 5. The number of program participants
who reported obtaining an additional supply of nicotine
patches, beyond the patches furnished by the NYSSQL,
was 11%. However, participants enrolled in the 2-week,
4-week and 6 week contingent programs (26.0%, 17.0%,
17.8% respectively) were more likely to have acquired
additional patches compared to callers who participated
in the 6-week and 8-week programs (2.8% and 3.1%,
respectively).
Smoking Outcomes
The smoking status outcomes for each of the five
groups are summarized in Table 4. Quit rates measured
at 12 months were higher for smokers in the groups
who received either 2 weeks of free patches (Group 1)
or the full 6 weeks (Group 4) or 8 weeks (Groups 5) of
free patches. The lowest quit rate was observed among
the group of Medicaid/uninsured smokers who were eli-
gible to receive up to six weeks of free patches, contin-
gent on their quitting efforts made within the first two
weeks of calling the quitline. The quit rate for Group 2
did not differ significantly from Groups 4 or 5.
Table 5 shows the mean differences between groups
on all smoking outcome measures. The asterisk signifies
that the differences between groups that are statistically
significant at the p < 0.05 level. What is evident from
the pattern of differences displayed in the table is that
there is no consistent dose response relationship
between the number of free patches given to smokers
and smoking status outcomes. For example, only three
group differences reached statistical significant at the
p < 0.05 level on our measure of 7-day nonsmoking pre-
valence at 12 months: group 2 (received 4 weeks of free
patches) had a lower quit rate relative to group 4 (New
York City group that received 6-week supply of patches);
group 3 (eligible for 6 weeks of free patches contingent
upon first 2 weeks) had a lower quit rate compared with
g r o u p s4a n d5( N e wY o r kC i t yg r o u pt h a tr e c e i v e d
6 weeks and uninsured group that received 8 weeks of
free patches). Notably, for the two groups that are most
similar in sampling and demographics (Groups 1 and 2),
no differences were found in quit rates for 2- vs. 4-week
supplies. Comparing the 2-week group (Group 1) to the
next most similar group (Group 4, received 6-week sup-
ply), again no differences were found in quit rates. For
the two Medicaid and/or uninsured groups (Groups 3
Table 3 Description of Nicotine Patch Usage
Number of free nicotine patches provided Group 1
2-week supply
Group 2
4-week supply
Group 3
6-week supply contingent
upon first 2-weeks of use
Group 4
6-week supply
Group 5
8-week supply
Number completed surveys 338 406 332 884 486
% Received free patches 97.9% 94.1% 98.2% 98.9% 98.6%
% Used any of the free patches 84.3% 82.3% 88.6% 88.9% 87.8%
Number of patches used†
0 patches 14.3% 15.2% 11.7% 11.4% 2.6%
1-7 patches 22.9% 24.9% 19.4% 16.9% 17.6%
8-14 patches 61.6% 43.0% 52.8% 10.6% 9.5%
15-28 patches 0.9% 12.6% 10.8% 22.0% 16.2%
29-42 patches 0.3% 3.4% 3.7% 39.2% 16.9%
43 + patches 0.0% 0.8% 1.5% 11.4% 37.1%
% Purchased additional NRT† 26.0% 17.0% 17.8% 2.8% 3.1%
† Chi-square test: p-value < 0.01.
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s u p p l yg r o u p( G r o u p5 ) ,t h o u g hn o td i f f e r e n tf r o mt h e
2-week insured group (Group 1). The pattern of differ-
ences observed between groups remains essentially the
same for the other outcome measures assessed.
Conclusions
Previous studies have observed that the odds of quit suc-
cess for smokers are greater in those who use NRT for a
longer duration [8-12]. However, this does not necessa-
rily mean that sending more free NRT to smokers who
call a quitline automatically increase their chances of
quitting and remaining smokefree. It is possible that the
generally higher quit success observed among those
reporting a longer duration of NRT is the result of self-
selection where those who quit and remain smokefree
continue to use their medication while those who relapse
discontinue use. For telephone quitlines and other stop
programs the question of how much nicotine medication
to give smokers to optimize quitting is a very practical
o n es i n c et h ed e s i r et op r o m o t eh i g h e rq u i tr a t e sn e e d s
to be balanced against limited resources available to assist
clients. This study utilized data collected from different
groups of smokers who had contacted the New York
Smokers Quiltine over the past 4 years and received dif-
ferent amounts of free nicotine patches to try to answer
Table 4 Smoking Outcomes by the Amount of Free Nicotine Patches Sent to Smokers
Number of free nicotine patches provided Group 1
2-week supply
Group 2
4-week supply
Group 3
6-week supply contingent
upon first 2-weeks of use
Group 4
6-week supply
Group 5
8-week supply
12-month quit rate* 31.0% 21.0% 15.5% 37.8% 31.1%
12-month intent-to-treat quit rate** 19.1% 12.9% 7.0% 23.1% 22.6%
Sustained quitters* 24.6% 20.3% 11.7% 27.3% 19.9%
Relapsed smokers* 18.9% 14.9% 16.4% 11.9% 10.2%
Delayed quitters* 6.4% 0.7% 3.8% 10.5% 11.3%
*adjusting for demographic characteristics (age, gender, and race), education level, and number of cigarettes smoked per day at the time of enrollment.
**non-responders are counted as smokers at the time of the 12-month follow-up survey.
Table 5 Mean differences on smoking outcome measures between groups
Mean Difference on Smoking Outcome Measures
Comparisons 12-month
quit rate
12-month intent-to-
treat quit rate
Sustained
quitters
Relapsed
smokers
Delayed
quitters
Group 1
2-week supply
Group 2
4-week supply
.05 .06 .01 .00 .03
Group 1
2-week supply
Group 3
6-week supply contingent upon
first 2-weeks of use
.07 .08* .05 -.01 .02
Group 1
2-week supply
Group 4
6-week supply
-.08 -.04 -.04 .08* -.04
Group 1
2-week supply
Group 5
8-week supply
-.05 -.05 -.03 .09* -.02
Group 2
4-week supply
Group 3
6-week supply contingent upon
first 2-weeks of use
.03 .03 .04 -.02 -.01
Group 2
4-week supply
Group 4
6-week supply
-.12* -.10* -.05 .07 -.07*
Group 2
4-week supply
Group 5
8-week supply
-.10 -.11* -.04 .09* -.06
Group 3
6-week supply contingent upon
first 2-weeks of use
Group 4
6-week supply
-.15* -.13* -.09 .09* -.06
Group 3
6-week supply contingent upon
first 2-weeks of use
Group 5
8-week supply
-.13* -.14* -.08 .10* -.04
Group 4
6-week supply
Group 5
8-week supply
.02 -.01 .01 .02 .01
Note: Group 1 = 2 weeks of patches; Group 2 = 4 weeks of patches; Group 3 = 6 weeks of patches contingent upon progress toward quitting measured at 2
weeks; Group 4 = 6-weeks of patches; Group 5 = 8 weeks of patches
*indicates significant difference in means between group compared is different at p < 0.05 level after the Bonferroni correction is applied
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to smokers affected quitting outcomes.
The findings from this study do not support the
hypothesis that sending more free nicotine patches to
smokers’ who call a quitline will reliably increase quit
rates. 12 month quit rates for each of the five groups
were examined in a multivariate logistic regression
model adjusting for age, gender, race, education level,
and number of cigarettes smoked per day at the time of
enrollment. Using the 2-week patch group as the refer-
ent category, we found odds ratios of 0.77 (95% CI:
0.49-1.21) for the 4-week patch group; 0.66 (95% CI:
0.40-1.10) for the group who received 6 weeks contin-
g e n tu p o nt h ef i r s t2w e e k so fu s e ;1 . 5 5( 9 5 %C I :1 . 0 8 -
2.21) for the 6-week patch group; and 1.33 (95% CI:
0.89-1.97) for the 8-week patch group. There was not a
clear cut dose response relationship observed between
the number of free nicotine patches sent to smokers
calling quitline and quit rates measured a year later sug-
gesting that it may not be cost-effective to send more
than a starter kit of free medications to smokers who
call requesting quitting assistance. However, NRT usage
patterns may help explain the equivocal cessation out-
comes observed. We did examine the correlation
between the number of patches used and quitting out-
comes in a multivariate logistic regression model adjust-
ing for the same covariates described above. In this
m o d e l ,w ed i do b s e r v ead o s er e s p o n s er e l a t i o n s h i p
between the number of patches used and odds ratios for
quitting. The higher odds ratios for quitting among par-
ticipants who used a greater number of patches is not
unexpected and most likely is the result of self selection
where those who quit and remain quit continue to use
the medication while thosew h or e l a p s ed i s c o n t i n u e
their use of medications.
The central goal of our analysis was not to test
whether using more patches was associated with higher
quit rates, but rather whether the number of free
patches sent to smokers calling a quitline would influ-
ence quit rates. The answer to this later question seems
to be that it does not make a huge difference in quit
rates. While those who were sent more free patches
reported using more patches, the number of days the
patch was used did not differ dramatically between the
groups. In other words those who got more free patches
appeared to have more left unused compared to those
who got only two weeks of free patches. Since the main
reason for discontinuing use of the patch is a return to
smoking, and since most relapses typically occurs within
the first few weeks of quitting, handing out a large sup-
ply of free patches at the start of someone’s quit attempt
does not guarantee a higher quit rate.
Caution is warranted in interpreting results from this
study as differences in the characteristics of the groups
compared could potentially account for the null find-
ings. A key difference among the five groups of smokers
compared in this study was how they were recruited
into the different arms. Groups 1, 2 and 3 were largely
self-selected callers responding to routine promotions of
the NYSSQL. Group 4 participants were all residents of
New York City who responded to a time limited, highly
publicized offer of free nicotine patches which coincided
with the implementation of the City’ss m o k e - f r e ew o r k
place law and increase in cigarette taxes. Group 5 parti-
cipants were unique in that they had all previously
called the NYSSQL for quitting assistance and were
recruited through a special direct mail campaign at
around the same time New York State implemented its
comprehensive smoke-free air law. Notably, however,
for the two groups whose recruitment was most similar
(Groups 1 and 2), there were no differences in outcomes
for 2- vs. 4-week supplies of NRT, and none of the
other groups had significantly higher quit rates than
Group 1 (2-week supply).
Another systematic difference between the groups
compared was their medical insurance status. Groups 1
and 2 included only privately insured persons while
group 5 included only uninsured persons. Group 3
included Medicaid and uninsured smokers, while group
4 included mainly privately insured persons, but also a
mix of publicly insured and uninsured smokers. While
previous studies have found an association between
medical insurance status and smoking cessation, this
association appears to be mediated by motivation to
quit smoking and amount smoked daily, both of which
are factors that we attempted to control for in this
study [20,21]. All five groups were matched on motiva-
tion to quit since as a condition of eligibility to get the
free patches smokers were required to set a quit date
within two weeks of calling the quitline in order to get
the free nicotine patches. The groups were also crudely
matched on amount smoked per day since as one of the
core criteria for eligibility for getting the free patches
smokers had to report smoking 10 or more cigarettes
per day. Adjustment for amount smoked daily using
analysis of covariance also did not change the results.
Another limitation of the study was low follow-up
response rates achieved, especially for the Medicaid and
uninsured group (group 3), whose overall response rate
was only 23 percent and much lower compared to the
other four groups. However, our analysis which counted
all non-responders as smokers did not alter the overall
conclusions reached about group differences.
In the current study, three-quarters or more of the
smokers in each of the five study groups reported smok-
ing at follow-up, which, while not unexpected, reflects
the obvious point that treatment outcomes still can be
improved upon. While the debate about how best to
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Page 7 of 9tailor the dose of NRT to smokers remains a hot topic
of research in the field of nicotine dependence treat-
ment, few have questioned the value of keeping smokers
on NRT for at least 8 to12 weeks [15-17,19,22]. While
the optimum duration of treatment needs to be better
understood, as important may be the proper dose of
medication given to smokers who are trying to quit.
Research has previously shown large individual variation
in smoking habits and in how different people metabo-
lize nicotine which in turn can influence the how people
respond to NRT [23-25]. Some researchers have specu-
lated that treatment outcomes with NRT could be
improved if the dose given to smokers trying to quit
could be more effectively matched to how they metabo-
lize nicotine [26-28]. In other words, single fixed dose
strength of nicotine patches does not necessarily fit all
smokers.
It is also possible that quit rates could be improved by
adding extra counseling calls beyond the one callback
provided to smokers. However, the extra counseling
calls provided to the Medicaid and uninsured smoker
group in this study did not appear to dramatically
increase quit rates over the other groups of smokers
that only received one counseling call. This result is
consistent with the null results of a recent trial evaluat-
ing the benefits of telephone counseling as an adjunct to
the use of medications for smoking cessation [29]. How-
ever, prior research has also indicated lower cessation
rates among Medicaid smokers, so it is possible that the
counseling calls improved quit rates over what would
have been achieved without the calls extra support calls
[20,21]. In addition, it is possible that making receipt of
the full 6-week supply contingent on using the first
2-weeks of NRT and completing a proactive call may
have influenced both follow-up completion rates and
outcomes for this group. Further examination of NRT
dosing specifically for Medicaid and uninsured smokers
is needed.
Smokers often cite the high cost of NRT as a barrier
preventing them from making a quit attempt [19]. Pre-
vious studies have demonstrated that offering free NRT
can be a safe and cost-effective inducement to get more
smokers to call a quitline [1-4]. However, this study
reveals that sending more free nicotine patches to smo-
kers who call a quitline does not automatically translate
into an enhanced duration of use or higher long term
quit rates. Given the inherent limitations in this quasi-
experimental study and the largely unchallenged
assumption about the importance of longer duration of
NRT therapy, we believe a more definitive randomized
controlled trial is warranted in order to test the cost-
effectiveness of giving smokers different amounts of free
NRT when they attempt to quit.
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